PBG Puerto Rico LLC
General
Total Cases24
Active Cases5
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/09/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (Attachments: # [1] Notice of Voluntary Dismissal)(kmd) (Entered: 09/09/2024) | |
| 09/06/24 | NOTICE of Voluntary Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (Dellinger, Megan) (Entered: 09/06/2024) | |
| 08/23/24 | STIPULATION TO EXTEND TIME for Defendants to Answer, Move, or Otherwise Respond to Plaintiffs' Complaint to September 9, 2024 - filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Myer, R.) (Entered: 08/23/2024) | |
| 08/20/24 | Letter to The Honorable Gregory B. Williams from Megan E. Dellinger regarding parties' joint technology tutorial. (Dellinger, Megan) (Entered: 08/20/2024) | |
| 08/16/24 | Summons Issued as to Ajanta Pharma Limited on 8/16/2024. (mws) (Entered: 08/16/2024) | |
| 08/16/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc. (mws) (Entered: 08/16/2024) | |
| 08/16/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mws) (Entered: 08/16/2024) | |
| 08/16/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/3/2024. Date of Expiration of Patent: 12/8/2025. Thirty Month Stay Deadline: See Attached (mws) (Entered: 08/16/2024) | |
| 08/16/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mws) (Entered: 08/16/2024) | |
| 08/16/24 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ajanta Pharma Limited (Filing fee $ 405, receipt number ADEDC-4478156.) - filed by Pfizer Inc., PBG Puerto Rico LLC, PF PRISM C.V., C.P. Pharmaceuticals International C.V., PF PRISM IMB B.V. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mws) (Entered: 08/16/2024) |